John D Lambris Selected Research

John D Lambris Research Topics

Disease

68	Inflammation (Inflammations) 01/2023 - 09/2002
26	Neoplasms (Cancer) 09/2023 - 02/2005
19	Sepsis (Septicemia) 01/2022 - 07/2002
17	Periodontitis 01/2023 - 02/2010
14	Infections 01/2022 - 11/2006
11	COVID-19 08/2022 - 01/2020
10	Macular Degeneration (Age-Related Maculopathy) 12/2020 - 11/2007
8	Thromboinflammation 01/2023 - 01/2013
8	Dysbiosis 10/2022 - 11/2012
8	Thrombosis (Thrombus) 01/2019 - 12/2003
8	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2018 - 03/2014
7	Hemolysis 01/2020 - 03/2014
6	Periodontal Diseases (Periodontal Disease) 10/2021 - 11/2011
6	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2008
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 06/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2012
4	Disease Progression 01/2020 - 05/2010
4	Wounds and Injuries (Trauma) 01/2020 - 03/2003
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 07/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017 - 08/2002
4	Fibrosis (Cirrhosis) 01/2017 - 10/2013
4	Respiratory Hypersensitivity 01/2013 - 03/2004
3	Hemorrhage 12/2021 - 12/2008
3	Thrombocytopenia (Thrombopenia) 11/2021 - 08/2010
3	Hemorrhagic Shock 01/2020 - 01/2019
3	Multiple Trauma (Multiple Injuries) 01/2019 - 11/2010
3	Kidney Diseases (Kidney Disease) 01/2019 - 01/2016
3	Edema (Dropsy) 01/2019 - 10/2013
3	Carcinogenesis 10/2018 - 10/2016
3	Rare Diseases (Rare Disease) 01/2016 - 09/2007
3	Smallpox (Variola) 06/2015 - 08/2003
3	Asthma (Bronchial Asthma) 01/2013 - 03/2006
3	Hereditary Complement Deficiency Diseases 11/2012 - 09/2007
2	Alveolar Bone Loss 10/2022 - 01/2011
2	Myocardial Infarction 01/2022 - 10/2018
2	Air Embolism (Gas Embolism) 01/2022 - 12/2021
2	Geographic Atrophy 01/2022 - 01/2020
2	Acute Lung Injury 01/2022 - 01/2021
2	Thrombotic Microangiopathies 11/2020 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2019
2	Pneumonia (Pneumonitis) 01/2020 - 01/2013
2	Multiple Organ Failure (MODS) 01/2019 - 08/2010
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2019 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 10/2016 - 01/2013
2	Reperfusion Injury 04/2014 - 12/2009
2	Stroke (Strokes) 04/2014 - 01/2007
2	Atherosclerosis 03/2014 - 02/2010
2	Immune System Diseases (Immune Disorders) 01/2013 - 11/2006

Drug/Important Bio-Agent (IBA)

146	Complement System Proteins (Complement)IBA 09/2023 - 08/2002
19	Anaphylatoxin C5a ReceptorIBA 01/2018 - 07/2002
18	compstatinIBA 01/2023 - 10/2006
14	Complement C3 (C3 Complement)IBA 10/2022 - 01/2003
12	Complement Inactivating AgentsIBA 01/2023 - 10/2004
12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2003
11	AnaphylatoxinsIBA 10/2018 - 10/2002
10	CytokinesIBA 11/2020 - 01/2003
8	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2003
8	Peptides (Polypeptides)IBA 03/2016 - 12/2003
7	AntibodiesIBA 11/2021 - 12/2002
6	AMY-101IBA 08/2022 - 09/2017
5	Complement Receptors (Complement Receptor)IBA 01/2023 - 04/2011
5	Complement C5a (Complement 5a)IBA 01/2022 - 12/2003
5	eculizumab FDA Link 11/2020 - 09/2007
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 09/2008
4	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 06/2006
4	Biocompatible Materials (Biomaterials)IBA 01/2013 - 01/2007
3	lepirudin (Refludan)FDA Link 01/2023 - 09/2002
3	CholesterolIBA 01/2022 - 03/2014
3	ChemokinesIBA 01/2021 - 11/2015
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019 - 10/2014
3	Interleukin-10 (Interleukin 10)IBA 10/2013 - 05/2010
3	Messenger RNA (mRNA)IBA 08/2009 - 07/2002
3	VaccinesIBA 02/2005 - 01/2003
2	EnzymesIBA 01/2023 - 10/2018
2	Therapeutic UsesIBA 01/2023 - 12/2021
2	Interleukin-17 (Interleukin 17)IBA 10/2022 - 12/2012
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022 - 01/2019
2	Complement C3-C5 Convertases (C3 Convertase)IBA 01/2022 - 05/2014
2	AntigensIBA 11/2021 - 04/2006
2	Immunoglobulin G (IgG)IBA 11/2021 - 10/2006
2	Toll-Like Receptor 4IBA 01/2021 - 01/2016
2	InterleukinsIBA 01/2021 - 04/2014
2	Thromboplastin (Tissue Factor)IBA 11/2020 - 06/2008
2	Thrombin FDA Link 11/2020 - 11/2010
2	Monoclonal AntibodiesIBA 11/2020 - 01/2014
2	Retinaldehyde (Retinal)IBA 01/2020 - 07/2015
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
2	Complement Factor H (Factor H)IBA 01/2019 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 10/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2010
2	Prostaglandins AIBA 01/2017 - 01/2016
2	CollagenIBA 11/2015 - 02/2014
2	Hemostatics (Antihemorrhagics)IBA 05/2014 - 08/2010
2	Peptide Hydrolases (Proteases)FDA Link 02/2014 - 10/2013

Therapy/Procedure

32	Therapeutics 01/2022 - 01/2003
5	Ligation 01/2023 - 07/2002
5	Renal Dialysis (Hemodialysis) 01/2019 - 01/2007
3	Immunotherapy 01/2019 - 01/2014
3	Transplantation 01/2016 - 01/2013